Key result
The Padua Prediction Score high-risk classification did not predict symptomatic venous thromboembolism compared to low-risk classification.
Why the study?
Venous thromboembolism is a leading safety concern during hospitalization, and the study aimed to evaluate the Padua Prediction Score's ability to predict VTE in Israeli non-surgical hospitalized patients.
Does the Padua Prediction Score accurately predict venous thromboembolism and does subsequent prophylactic anticoagulation reduce VTE in non-surgical hospitalized patients?
Cohort (n=5,117)
No
Does the Padua Prediction Score accurately predict venous thromboembolism and does subsequent prophylactic anticoagulation reduce VTE in non-surgical hospitalized patients?
Answers are grounded in this paper and cite their sources.
The Padua Prediction Score was not an efficient tool for identifying non-surgical hospitalized patients at high risk for clinically significant VTE, and prophylactic anticoagulation based on it did not provide significant clinical benefit.
Venous thromboembolism (VTE) is considered a leading safety concern during hospitalization. The Padua Predication Score (PPS) is a risk model conceived to predict VTE among non-surgical hospitalized patients. The study aim was to evaluate the PPS ability to predict VTE in Israeli non-surgical hospitalized patients using data from electronic medical records. A single center, large-scale, historic cohort study of hospitalized non-surgical patients was conducted. Outcomes included clinically diagnosed symptomatic VTE events, bleeding events, and mortality during hospitalization and up to 90 days thereafter, and readmission up to 90 days after discharge. 5117 patient records were analyzed after screening and validation. 1120 (22%) patients were defined per PPS as high-risk, of which 277 (24.7%) were prophylactically treated. The low-risk group included 3997 (78%) patients. Prevalence of symptomatic VTE was low. Overall, 14 (0.27%) VTE events were diagnosed: 3 cases in the high-risk group (0.27%) and 11 (0.28%) in the low-risk group, with no significant difference, p = 0.768. Prophylactic treatment among the high-risk patients did not significantly improve VTE incidence: 1/277 (0.36%) treated vs. 2/843 (0.24%), p = 0.343. There was no significant difference between the study groups regarding the rates of bleeding, unexplained mortality or readmission. PPS was not found to be an efficient tool for identification of non-surgical hospitalized patients with high risk for clinically significant VTE.
No takes yet. Share an insight, caveat, or question.
Lavon et al. (2022) conducted a cohort in Venous thromboembolism risk in non-surgical hospitalized patients (n=5,117). Padua Prediction Score (PPS) high-risk status (PPS ≥ 4) vs. PPS low-risk status (PPS < 4) was evaluated on Clinically diagnosed symptomatic VTE events (aRR 1.292, 95% CI 0.237-7.052, p=0.768). The Padua Prediction Score high-risk classification did not predict symptomatic venous thromboembolism compared to low-risk classification.
Synapse has enriched 10 related papers. Consider them for comparative context: